Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
[Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin]M George, M H Pejovic, M Thuaire, et al.
Cancer|November 1, 1989
Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumorsM Azab, J P Droz, C Theodore, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 27, 1978
[Response to an antiestrogen as a criterion for hormonal sensitivity of endometrial cancer]P Robel, C Lévy, J P Wolff, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|July 1, 1974
[Ovarian dysgerminoma: clinical signs, assessment, and therapeutic indications, with reference to 30 observations]D Sarrazin, F Fontaine, J P Wolff, et al.
Contraception, Fertilite, Sexualite (1992)|February 1, 1993
[Value of microfertilization for repeated in vitro fertilization failures: the role of female parameters]R Fanchin, J P Wolff, D de Ziegler, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1986
[Advanced cancer of the ovary. Treatment and results]J P Wolff, M George, P Duvillard, et al.
La Nouvelle Presse Medicale|June 28, 1980
[The management of ovarian adenocarcinoma. "Second look" surgical operation after chemotherapy (author's transl)]J L Misset, R Marnich, G Michel, et al.
Gynecologic Oncology|January 1, 1986
New treatment procedure for stage I endometrial adenocarcinomaJ P Wolff, M H Pejovic, G Michel, et al.
Gynecologic Oncology|February 1, 1987
Combination cyclophosphamide, adriamycin, and cis-platinum in recurrent and metastatic cervical carcinomaE O De Murua, M George, M H Pejovic, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group StudyC F de Oliveira, A J Lacave, C Villani, et al.
Pageof 2